| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J2507 |
Injection, pegloticase, 1 mg |
73 |
49 |
$180K |
| J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
812 |
732 |
$75K |
| J1602 |
Injection, golimumab, 1 mg, for intravenous use |
323 |
317 |
$53K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
3,177 |
3,164 |
$48K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,104 |
1,097 |
$35K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
1,209 |
1,206 |
$33K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,273 |
7,048 |
$31K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,412 |
2,409 |
$28K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,189 |
6,947 |
$26K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,446 |
2,441 |
$24K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,491 |
1,289 |
$21K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
342 |
338 |
$14K |
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
357 |
330 |
$10K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
855 |
849 |
$6K |
| 99243 |
|
513 |
513 |
$1K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,181 |
1,050 |
$1K |
| 96401 |
|
586 |
523 |
$1K |
| 96415 |
|
447 |
338 |
$955.23 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
593 |
451 |
$455.77 |
| J0490 |
Injection, belimumab, 10 mg |
102 |
76 |
$422.94 |
| 99152 |
|
238 |
236 |
$351.45 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
178 |
163 |
$225.00 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
247 |
203 |
$192.70 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
56 |
37 |
$102.20 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
174 |
135 |
$73.51 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
79 |
77 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
12 |
12 |
$0.00 |
| 4040F |
|
73 |
70 |
$0.00 |
| G8421 |
Bmi not documented and no reason is given |
42 |
41 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
102 |
99 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
43 |
41 |
$0.00 |